Clinical investigation of medicinal products to prevent development/slow progression of chronic renal insufficiency

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/500825/2016
Published20/10/2016
Effective from01/04/2017
KeywordsRenal insufficiency, chronic kidney disease (CKD)
DescriptionThe document provides guidance on the conduct of clinical studies with medicinal products intended to prevent or slow progression of chronic renal insufficiency. It defines treatment goals, study designs, outcome measures and data analyses.


Document history

First version

Current version

Adopted guideline

 

Overview of comments

 

Draft guideline

 

Concept paper

Effective from: 01/04/2017

 

Published: 20/10/2016

 

Published: 01/07/2014

 

Published: 20/09/2010


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more